Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation in acute leukemia.

E Beutler, R McMillan

    Blood Cells
    |January 1, 1982
    PubMed
    Summary

    Bone marrow transplantation offers superior outcomes for acute leukemia patients in first remission compared to chemotherapy. However, graft-versus-host disease (GVHD) remains a significant challenge, prompting research into T-lymphocyte depletion and new immunosuppressive drugs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    1342C mutation in Gaucher's disease.

    Lancet (London, England)·1995
    Same author

    Triosephosphate isomerase deficiency: repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families.

    American journal of hematology·1995
    Same author

    Gaucher disease.

    Medicine·1995
    Same author

    Treatment regimens in Gaucher's disease.

    Lancet (London, England)·1995
    Same author

    Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.

    The Journal of clinical investigation·1995
    Same author

    Erythrocyte fragility and chronic intermittent pigmenturia in a dog.

    Journal of the American Veterinary Medical Association·1995

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Bone marrow transplantation (BMT) emerged as a critical treatment for acute leukemia refractory to conventional therapies.
    • Early BMT results showed promise, particularly in patients achieving first remission.

    Purpose of the Study:

    • To evaluate the efficacy of bone marrow transplantation in acute leukemia patients.
    • To identify and address the primary causes of mortality post-transplantation.

    Main Methods:

    • Analysis of outcomes for acute leukemia patients undergoing bone marrow transplantation.
    • Investigating methods to mitigate graft-versus-host disease (GVHD), including T-lymphocyte depletion and novel immunosuppressive agents.

    Main Results:

    • BMT demonstrated superior outcomes compared to chemotherapy in acute leukemia patients in first remission.
    • Leukemic relapse was infrequent in this cohort.
    • Graft-versus-host disease (GVHD) was identified as the principal cause of mortality, affecting approximately 40% of patients.

    Conclusions:

    • Bone marrow transplantation is a highly effective treatment for acute leukemia in first remission.
    • Reducing GVHD incidence and severity is crucial for improving BMT survival rates.
    • Ongoing research focuses on T-lymphocyte depletion and advanced immunosuppression to enhance BMT safety and efficacy.

    Related Experiment Videos